Study of inflammation in prostate carcinogenesis
Project/Area Number |
24592388
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Osaka University |
Principal Investigator |
NONOMURA Norio 大阪大学, 医学(系)研究科(研究院), 教授 (30263263)
|
Co-Investigator(Kenkyū-buntansha) |
NAKAI Yasutomo 大阪大学, 医学系研究科, 講師 (20432479)
TAKAYAMA Hitoshi 大阪大学, 医学系研究科, 講師 (50403051)
FUJITA Kazutoshi 大阪大学, 医学系研究科, 助教 (50636181)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 前立腺 / 発癌 / 炎症 / 骨髄由来細胞 / 前立腺癌 / 幹細胞 / 再生 |
Outline of Final Research Achievements |
Using chimera rats that received allogenic bone marrow grafts from green fluorescent protein (GFP) transgenic rats , we investigated the existence of epithelial marker-positive BMDCs in injured prostate tissue caused by transurethral injection of lipopolysaccharide. Immunofluorescence staining showed that some cells in the stroma co-expressed GFP and pan-cytokeratin, which suggested the existence of epithelial marker-positive BMDCs. We collected bone marrow-derived non-hematopoietic cells (GFP+/CD45- cells) from the prostate. The number of cells in this population significantly increased in injured prostate compared with normal prostate tissue.In the prostate obtained from the chimera rats 34 weeks after lipopolysaccharide injection, GFP- and cytokeratin-positive cells were observed in the prostate gland, which suggested that some of the cells in the prostate gland regenerated after prostate inflammation derived from bone marrow.
|
Report
(4 results)
Research Products
(22 results)
-
[Journal Article] Evaluation of PSF1 as a prognostic biomarker for prostate cancer.2015
Author(s)
Tahara H, Naito H, Kise K, Wakabayashi T, Kamoi K, Okihara K, Yanagisawa A, Nakai Y, Nonomura N, Morii E, Miki T, Takakura N
-
Journal Title
Prostate Cancer Prostatic Dis
Volume: 18
Issue: 1
Pages: 56-62
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
[Journal Article] DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.2014
Author(s)
Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Hirata H, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Dahiya R, Tanaka Y.
-
Journal Title
Oncotarget
Volume: 5
Pages: 11297-11307
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc2013
Author(s)
Hatano K, Yamaguchi S, Nimura K, Murakami K, Nagahara A, Fujita K, Uemura M, Nakai Y, Tsuchiya M, Nakayama M, Nonomura N, *Kaneda Y.
-
Journal Title
Mol Cancer Research
Volume: 11
Issue: 9
Pages: 1088-1100
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.2013
Author(s)
Sato M, Nakai Y, Nakata W, Yoshida T, Hatano K, Kawashima A, Fujita K, Uemura M, Takayama H, Nonomura N
-
Journal Title
PLoS One.
Volume: 20
Issue: 9
Pages: e74313-e74313
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-